CGH
CPRX

Crossmark Global Holdings’s Catalyst Pharmaceutical CPRX Stock Holding History

Crossmark Global Holdings’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Hold
11,441
– – ﹤0.01% 996
2026
Q1 		$283K Hold
11,441
– – ﹤0.01% 1050
2025
Q4 		$267K Buy
+11,441
New +$255K ﹤0.01% 1075

Other funds holding CPRX

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
LTAS
Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Crossmark Global Holdings's CPRX Position: Q2 2026 in Review

Crossmark Global Holdings held its Catalyst Pharmaceutical (CPRX) position steady in Q2 2026 at 11,441 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #996.

Crossmark Global Holdings first reported a position in CPRX in Q4 2025 and has held it in 3 quarters since. 36 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Crossmark Global Holdings held 11,441 shares of Catalyst Pharmaceutical worth $360K as of Q2 2026.
  • Crossmark Global Holdings left its Catalyst Pharmaceutical share count unchanged in Q2 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #996 holding.
  • Crossmark Global Holdings first reported a position in Catalyst Pharmaceutical in Q4 2025 and has held it in 3 quarters since.
  • 36 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.